Blog

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

January, 2025

Blog

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

Photo from faculty.mdanderson.org

Jun 26, 2023, 18:40

Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML

In a post by Jared K. Burks on Linkedin, it says, “This is a double celebration as not only did I get to contribute to this wonderful article, but the first author, Russell Pourebrahim was just promoted to Assistant Professor. Congrats Rasoul on both the article and the promotion, very happy for you.
Mesenchymal stromal cells (MSCs) are a key component of the bone marrow (BM) niche, providing essential support required for the maintenance of hematopoietic stem cells. To advance our understanding of physiological functions of p53 and Mdm2 in BM-MSCs, we developed traceable conditional mouse models targeting Mdm2 and/or Trp53 in vivo. Our results reveal a physiologic function of Mdm2 in BM-MSC, identify a previously unknown role of p53 pathway in BM-MSC–mediated support in AML and expand our understanding of the mechanism of hematopoietic toxicity of MDM2is.”

For Article : Click here

Source:

bone marrow cancer cancer care hematopoietic Jared K. Burks Mesenchymal stromal cells Oncology Research Russell Pourebrahim

'

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

'

Monica Bertagnolli is ending her tenure as NIH director

'

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

'

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

'

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Blog

Jan 18, 2025, 15:27

Karen Knudsen: Accelerating the development and deployment of innovative radioligand therapies for cancer

Blog

Jan 18, 2025, 15:20

Manju George: Fascinating discussion on DPD testing

Blog

Jan 18, 2025, 14:58

The latest IACH News podcast by William Wesson

Blog

Jan 18, 2025, 14:50

Don’t miss the 11th World Congress of Melanoma and 21st EADO Congress

Blog

Jan 18, 2025, 14:46

Karen Knudsen: Identifying the science that can truly change the trajectory of cancer care

Opinion

Jan 18, 2025, 14:43

Introducing the members of the Steering Committee of the Global Childhood Cancer Survivors Network - CCI

Opinion

Jan 18, 2025, 14:43

Omnia Korani: Apply for the Improving Cancer Outcomes and Leadership Course

Blog

Jan 18, 2025, 14:40

GHN Psychosocial Wellbeing WG Meeting - SIOP

Blog

Jan 18, 2025, 14:33

Aleix Prat - Celebrating Progress at the DEFINITIVE Annual Meeting

Blog

Jan 18, 2025, 14:31

Aruni Ghose: Pleasure Catching Up with Ankit Jain and Exploring OncoFlow’s Future at Apollo Hospitals

Blog

Jan 18, 2025, 14:28

Jordan Rathkopf: Burden of Concealment - The Diagnosed, The Caregiver, and Their Son

Blog

Jan 18, 2025, 14:11

Sharing the latest interactive modules on integrative medicine for cancer-related pain and anxiety/depression - SIO